Form 8-K - Current report:
SEC Accession No. 0001193125-18-260639
Filing Date
2018-08-28
Accepted
2018-08-28 16:30:59
Documents
4
Period of Report
2018-08-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d614839d8k.htm 8-K 27511
2 EX-2.1 d614839dex21.htm EX-2.1 573594
3 EX-99.1 d614839dex991.htm EX-99.1 18582
4 GRAPHIC g614839logo.jpg GRAPHIC 3736
  Complete submission text file 0001193125-18-260639.txt   626292
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 181041942
SIC: 2834 Pharmaceutical Preparations